Tonghua Shuanglong Acquires Jinbao Pharma for $178 Million

Tonghua Shuanglong Chemical will pay 1.1 billion RMB ($178.2 million) to acquire Jinbao Pharmaceutical Co., in a deal that combines cash and stock. Jinbao is a TCM company. Shuanglong explained that its existing business is entirely dependent on sales of silica products and felt the need to diversify. More details.... Stock Symbol: (SHE: 300108) Share this with colleagues: // //